Effectdossier · gearchiveerd kwartaal
PVLA
Palvella Therapeutics, Inc. · Healthcare · Biotechnology
62Gevolgde houders
+2Δ houders
4.35MGehouden aandelen
$454.99MGerapporteerde waarde
+2Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +3.3% ·
aandelenstroom +4.2% ·
netto nieuwe posities +3.2%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +9 | 6.93M | $1.05B | +11 | −2 |
| Q1 2026 | 76 | +14 | 6.06M | $750.08M | +17 | −3 |
| Q4 2025 | 62 | +2 | 4.35M | $454.99M | +2 | n/a |
| Q3 2025 | 14 | +3 | 2.25M | $140.88M | +4 | −1 |
| Q2 2025 | 8 | 0 | 1.30M | $29.21M | n/a | n/a |
| Q1 2025 | 5 | +2 | 421.70K | $11.80M | +3 | −1 |
| Q4 2024 | 3 | +3 | 46.05K | $552,635 | +3 | n/a |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 560.62K | +13.3% | $58.68M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 559.07K | +14.7% | $58.52M | 0.0% | ▲ Add | 3 | SEC ↗ ×8 |
| 3 | State Street Global Advisors ✦ (passief) | 420.46K | +206.3% | $44.01M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Jennison Associates Llc | 387.48K | n/a | $40.56M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Federated Hermes, Inc. | 368.04K | n/a | $38.52M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Alliancebernstein L.P. | 269.03K | n/a | $28.16M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 231.76K | +109.8% | $24.26M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | Morgan Stanley ✦ | 220.66K | +59.3% | $23.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 9 | Artisan Partners Limited Partnership | 211.55K | n/a | $22.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 178.99K | +6.5% | $18.74M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Balyasny Asset Management L.P. | 108.88K | n/a | $11.40M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 98.94K | -58.2% | $10.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 13 | Point72 Asset Management ✦ | 77.30K | -75.6% | $8.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Clearbridge Investments, LLC | 60.63K | n/a | $6.35M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Northern Trust Corp | 54.49K | n/a | $5.70M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | Invesco Ltd. | 54.27K | n/a | $5.68M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 17 | UBS AM, a distinct business unit of… | 47.68K | n/a | $4.99M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 18 | Neuberger Berman Group LLC | 44.90K | n/a | $4.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 19 | UBS Group AG | 36.51K | n/a | $3.82M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 20 | Bank Of America Corp /De/ | 30.27K | n/a | $3.17M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 21 | Barclays Plc | 25.14K | n/a | $2.63M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 22.53K | -74.9% | $2.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 22.40K | -5.5% | $2.34M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 24 | Raymond James Financial Inc | 22.26K | n/a | $2.33M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 25 | Charles Schwab Investment… | 21.63K | n/a | $2.26M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Nuveen, LLC | 19.58K | n/a | $2.05M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 27 | New York State Common Retirement… | 17.32K | n/a | $1.81M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Bank of New York Mellon Corp | 16.26K | n/a | $1.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 29 | Swiss National Bank | 14.20K | n/a | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Victory Capital Management Inc | 14.12K | n/a | $1.48M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Sei Investments Co | 11.72K | n/a | $1.23M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 32 | Mariner, LLC | 11.62K | n/a | $1.22M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Wells Fargo & Company/Mn | 10.93K | n/a | $1.14M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 34 | Marshall Wace ✦ | 9.48K | Nieuw | $992,690 | 0.0% | New | 1 | SEC ↗ ×2 |
| 35 | Rhumbline Advisers | 8.64K | n/a | $903,921 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | California State Teachers… | 6.92K | n/a | $724,212 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Deutsche Bank Ag\ | 6.59K | n/a | $690,194 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 38 | Brown Advisory Inc | 6.38K | n/a | $667,690 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Legal & General Group Plc | 5.85K | n/a | $612,215 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 40 | JPMorgan Chase ✦ | 5.01K | -42.3% | $523,978 | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 41 | Franklin Resources Inc | 4.65K | n/a | $486,716 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 42 | State Of Wisconsin Investment Board | 4.51K | n/a | $472,376 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 4.31K | n/a | $446,312 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 44 | T. Rowe Price ✦ | 4.09K | +11.8% | $429,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Two Sigma Investments ✦ | 4.09K | 0.0% | $428,100 | 0.0% | Held | 2 | SEC ↗ |
| 46 | Janus Henderson Group Plc | 3.60K | n/a | $376,164 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Millennium Management ✦ | 3.48K | -87.0% | $364,252 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | LPL Financial LLC | 3.45K | n/a | $360,902 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Creative Planning | 2.96K | n/a | $310,137 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Citadel Advisors ✦ | 2.64K | Nieuw | $275,910 | 0.0% | New | 1 | SEC ↗ |
| 51 | Royal Bank Of Canada | 2.30K | n/a | $240,000 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 52 | Manufacturers Life Insurance… | 2.27K | n/a | $237,601 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Citigroup Inc | 2.00K | n/a | $209,759 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 54 | Russell Investments Group, Ltd. | 1.23K | n/a | $128,639 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 55 | Bnp Paribas Financial Markets | 470 | n/a | $49,195 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Us Bancorp \De\ | 335 | n/a | $35,064 | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Group One Trading Llc | 332 | n/a | $34,750 | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Pnc Financial Services Group, Inc. | 30 | n/a | $3,140 | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Cwm, Llc | 26 | n/a | $3,000 | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Jones Financial Companies Lllp | 6 | n/a | $628 | 0.0% | n/c | 1 | SEC ↗ |
| 61 | Rockefeller Capital Management L.P. | 5 | n/a | $523 | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Osaic Holdings, Inc. | 2 | n/a | $209 | 0.0% | n/c | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Marshall Wace | $992,690 | 0.0% |
| Citadel Advisors | $275,910 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 181 houders, 13.20M aandelen, $1.59B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Oct 14
JENKINS GEORGE M
Director · 476 aand · $57,663
Oct 14
JENKINS GEORGE M
Director · 505 aand · $63,910
Oct 14
JENKINS GEORGE M
Director · 597 aand · $74,820
Oct 14
JENKINS GEORGE M
Director · 920 aand · $114,416
Oct 14
JENKINS GEORGE M
Director · 2.60K aand · $321,046
Oct 14
JENKINS GEORGE M
Director · 2.07K aand · $254,058
Oct 13
JENKINS GEORGE M
Director · 1.64K aand · $212,455
Oct 13
JENKINS GEORGE M
Director · 922 aand · $123,292
Oct 13
JENKINS GEORGE M
Director · 579 aand · $76,662
Oct 13
JENKINS GEORGE M
Director · 1.03K aand · $136,092
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
Aug 14
SC 13G/A: First Light Asset Management, LLC
Aug 14
SC 13G/A: BIOTECHNOLOGY VALUE FUND L P
Aug 10
SC 13G: PRUDENTIAL FINANCIAL INC
Aug 03
SC 13G: JENNISON ASSOCIATES LLC
Jul 29
SC 13G: BlackRock, Inc.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API